Healthcare Reforms Under the IRA: Expanding Access to Care
Healthcare Law Blog
AUGUST 25, 2022
Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Program Compliance. Drug manufacturers may also be assessed an excise tax between 65%-95% depending upon the number of days that the drug manufacturer is out of compliance. Negotiation-Eligible Drugs.
52 
Let's personalize your content